G&S Capital LLC trimmed its position in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 2.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 25,727 shares of the financial services provider’s stock after selling 609 shares during the quarter. G&S Capital LLC’s holdings in Aflac were worth $2,661,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also recently bought and sold shares of the company. Darwin Wealth Management LLC purchased a new position in Aflac during the third quarter worth about $34,000. Raelipskie Partnership purchased a new position in shares of Aflac in the 3rd quarter worth approximately $38,000. Covestor Ltd grew its holdings in shares of Aflac by 41.8% in the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock valued at $41,000 after acquiring an additional 107 shares in the last quarter. Kennebec Savings Bank purchased a new stake in shares of Aflac during the third quarter valued at approximately $45,000. Finally, Catalyst Capital Advisors LLC bought a new stake in Aflac during the third quarter worth $51,000. 67.44% of the stock is owned by hedge funds and other institutional investors.
Aflac Stock Performance
Shares of AFL opened at $102.98 on Thursday. Aflac Incorporated has a 52-week low of $77.01 and a 52-week high of $115.50. The stock’s 50-day simple moving average is $104.33 and its 200 day simple moving average is $107.05. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. The stock has a market capitalization of $57.21 billion, a price-to-earnings ratio of 10.73, a price-to-earnings-growth ratio of 2.10 and a beta of 0.99.
Aflac Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Monday, March 3rd. Investors of record on Wednesday, February 19th will be paid a $0.58 dividend. This represents a $2.32 dividend on an annualized basis and a yield of 2.25%. The ex-dividend date of this dividend is Wednesday, February 19th. This is a boost from Aflac’s previous quarterly dividend of $0.50. Aflac’s dividend payout ratio is currently 20.83%.
Insider Activity at Aflac
In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the business’s stock in a transaction that occurred on Friday, December 27th. The stock was sold at an average price of $103.40, for a total value of $2,558,529.60. Following the completion of the sale, the executive vice president now owns 222,618 shares in the company, valued at approximately $23,018,701.20. The trade was a 10.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.90% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
A number of research analysts have issued reports on AFL shares. Keefe, Bruyette & Woods reduced their price objective on Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a research note on Wednesday. BMO Capital Markets started coverage on shares of Aflac in a research report on Thursday, January 23rd. They set a “market perform” rating and a $111.00 price target for the company. Wells Fargo & Company lifted their price objective on shares of Aflac from $103.00 to $104.00 and gave the stock an “equal weight” rating in a research report on Tuesday, January 14th. Piper Sandler reduced their target price on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating for the company in a research report on Friday, February 7th. Finally, Truist Financial lifted their price target on shares of Aflac from $100.00 to $105.00 and gave the stock a “hold” rating in a report on Friday, November 1st. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $103.00.
Read Our Latest Stock Report on Aflac
Aflac Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Read More
- Five stocks we like better than Aflac
- Do ETFs Pay Dividends? What You Need to Know
- Will Eli Lilly Stock Keep Climbing? Q2 Trial Results Are Crucial
- 5 discounted opportunities for dividend growth investors
- Double-Digit Gains Ahead? These 2 Cybersecurity Stocks Look Ready
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Will Falling Bond Yields Send These 2 Small Caps Soaring?
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.